No Data
ISHINDO: 2024 ANNUAL REPORT
Isshintang: 2025 First Quarter Report
Isshintang: 2024 Annual Report Summary
Yixintang Pharmaceutical (002727.SZ): Net income in the first quarter was 0.16 billion yuan, a year-on-year decrease of 33.83%.
On April 27, Gelonghui reported that Yixintang Pharmaceutical (002727.SZ) announced its first-quarter report for 2025, showing revenue of 4.767 billion yuan, a year-on-year decrease of 6.53%; net income attributable to shareholders of the listed company was 0.16 billion yuan, down 33.83% year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.157 billion yuan, a year-on-year decrease of 36.27%; EPS was 0.2733 yuan.
Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital Not Reflecting Well On The Business
Yixintang Pharmaceutical Group (SZSE:002727) Stock Falls 4.9% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend
4.8% Earnings Growth Over 3 Years Has Not Materialized Into Gains for Yixintang Pharmaceutical Group (SZSE:002727) Shareholders Over That Period
